The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global anesthesia endotracheal tubes market reached a value of US$ 162.79Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 227.31Million by 2027, exhibiting a CAGR of 5.83% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Anesthesia endotracheal tubes (ETTs) are used for intubation and manufactured using a polyvinylchloride (PVC) tube, which is inserted into the trachea and allows direct delivery of oxygen (O2) and removal of carbon dioxide (CO2) from the lungs. They aid in maintaining the airway passage of the lungsand allowing mechanical ventilation. They are also utilizedfor protecting the lungs from contamination of gastric contents and nasopharyngeal matter and during intermittent positive pressure ventilation (IPPV), resuscitation, Diptheria, epiglottis, and direct suctioning of the trachea in meconium aspiration. They enable healthcare professionals to sedate the patient and performing the surgical procedure. As a result, ETTsare widely used in surgery centers, trauma centers, and intensive care units (ICUs).
The increasing prevalence of chronic disorders and viral infections among the masses, especially the geriatric population, which is more susceptible to thesemedical ailments, represents one of the major factors positively influencing the demand for anesthesia ETTs worldwide. In addition, the rising number of fatal road accidents and the growing number of trauma cases are driving the market. Apart from this, key players are introducing anesthesia ETTs with flexible tips that offer enhanced comfort and convenience to the users and assist in navigating through fragile airways with minimal discomfort. Furthermore, the escalating number of smokers and alcohol consumers is contributing to the market growth. Moreover, increasing incidences of airborne diseases on account of the rising air pollution arecreating a positive outlook in the market. Besides this, the expanding investments in improving healthcare infrastructure and medical services are projected to offer lucrative growth opportunities to industry investors.
IMARC Group provides an analysis of the key trends in each sub-segment of the global anesthesia endotracheal tubes market report, along with forecasts for growth at the global and regional level from 2022-2027. Our report has categorized the market based on region, intubation type, product type, and end user.
Breakup by Intubation Type:
Nasotracheal intubation dominates the market as it is easier to secure, moves less, minimizes the risk of trauma to lips, tongue, and larynx, and provides comfort to patients.
Breakup by Product Type:
Coated tubes currently dominate the market.
Breakup by End User:
Anesthesia endotracheal tubes are extensively used in hospitals as it is an emergency procedure performed on people to maintain an open airway and help prevent suffocation.
Breakup by Region:
North America holds the majority of the global anesthesia endotracheal tubes market share due to the increasing prevalence of severe chronic ailments among the masses of the region.
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Becton, Dickinson and Company, Convatec Limited, Fuji Systems Corp., General Electric (GE) Company, Intersurgical Ltd., Medtronic Private Limited, Neurovision Medical Products, SEWOON MEDICAL Co., Ltd., Smiths Group PLC, and Teleflex Incorporated.
|Base Year of the Analysis||2021|
|Segment Coverage||Intubation Type, Product Type, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||C. R. Bard, Inc. (Becton, Dickinson and Company), ConvaTec Group Plc, Fuji Systems Co., Ltd., General Electric Company, Intersurgical Inc, Medtronic Plc, Neurovision Medical Products, Sewoon Medical Co., Ltd., Smiths Medical, and Teleflex Incorporated.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at